North America Pulse Oximeter Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Type (Handheld Oximeters, Fingertip Oximeters, Tabletop Oximeters), End-Use and Country (the United States, Canada and Rest of North America) - Industry Analysis From 2026 to 2034
The North America pulse oximeter market size was valued at USD 0.92 billion in 2024 and is estimated to reach USD 1.80 billion by 2033 from USD 0.99 billion in 2025, registering a CAGR of 7.69% from 2025 to 2033.
The North America pulse oximeter market refers to the non-invasive medical devices that measure blood oxygen saturation levels and pulse rate. These devices are widely used in both clinical and home healthcare settings for monitoring respiratory and cardiovascular health. Pulse oximeters have become essential tools in managing chronic conditions such as COPD, asthma, and sleep apnea, as well as during post-operative recovery and critical care scenarios. According to the American Thoracic Society, over 16 million Americans suffer from chronic obstructive pulmonary disease (COPD), highlighting the increasing need for continuous oxygen monitoring. As per Statistics Canada, respiratory diseases remain a leading cause of hospitalization among the elderly population, further reinforcing the demand for reliable monitoring technologies across the country. Moreover, the rise in telehealth services and home-based patient monitoring has expanded the adoption of portable and fingertip pulse oximeters beyond traditional healthcare facilities.
One of the primary drivers of the North America pulse oximeter market is the rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung disease. These conditions necessitate regular monitoring of blood oxygen levels to manage symptoms and prevent acute exacerbations. In Canada, the Canadian Lung Association reported that approximately 3.8 million people live with asthma, and COPD affects nearly 2.4 million individuals, making long-term oxygen monitoring a necessity for millions across the region. As per the American College of Chest Physicians, routine use of pulse oximeters has been shown to improve disease management and reduce hospital readmission rates among patients with chronic respiratory ailments. This growing reliance on continuous oxygen saturation monitoring is driving demand for both clinical and personal-use pulse oximeters, particularly among older adults and high-risk populations.
A significant driver fueling the growth of the North America pulse oximeter market is the rapid expansion of home healthcare services and the widespread adoption of telemedicine platforms. With an increasing emphasis on remote patient monitoring, especially following the global health crisis, pulse oximeters have become integral components of home diagnostic kits. Remote monitoring of vital signs, including blood oxygen saturation, has become a standard practice in these consultations, necessitating access to accurate and portable pulse oximeters. In Canada, provincial health authorities have integrated pulse oximetry into community-based care programs for seniors and individuals with chronic illnesses.
A key restraint affecting the North America pulse oximeter market is the increasing regulatory scrutiny regarding the accuracy and performance consistency of commercially available devices, particularly those marketed for consumer use. Concerns over reliability especially among diverse skin tones have prompted stricter evaluation protocols by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and Health Canada. According to a 2023 report by the FDA, some low-cost fingertip pulse oximeters exhibited inaccuracies in measuring blood oxygen saturation levels, particularly in individuals with darker skin pigmentation. This raised concerns about potential misdiagnoses or delayed treatment decisions based on faulty readings, prompting calls for enhanced validation standards. In response, the FDA issued updated guidelines requiring more rigorous testing before granting clearance for new pulse oximeter models. Similarly, Health Canada emphasized the importance of multi-ethnic clinical trials in device certification processes.
Another critical constraint influencing the North America pulse oximeter market is the ongoing volatility in global supply chains and shortages of critical electronic components required for device manufacturing. The semiconductor shortage that began in 2021 has continued to impact production timelines and cost structures for many medical device companies. According to the U.S. Department of Commerce, semiconductor lead times remained extended into 2024, affecting industries reliant on microchips, including medical diagnostics. Many pulse oximeter manufacturers experienced delays in sourcing essential sensors and microprocessors, resulting in reduced output and longer delivery cycles. As per Deloitte’s 2024 supply chain analysis, logistics costs for medical equipment imports into North America rose by 15% in the past year, further straining operational margins.
An emerging opportunity for the North America pulse oximeter market lies in the integration of pulse oximetry technology into wearable and smart health devices. As consumer interest in real-time health tracking continues to grow, tech companies are increasingly embedding pulse oximeters into smartwatches, fitness bands, and other wearables to offer advanced biometric monitoring capabilities.
According to the Consumer Technology Association (CTA), shipments of health-focused wearable devices in the U.S. grew by 18% in 2023, with oxygen saturation monitoring becoming a key differentiator among premium models from brands like Apple, Fitbit, and Whoop. These integrations enable users to monitor their respiratory health continuously, particularly during physical activity or at high altitudes. In Canada, the Digital Health Canada initiative has encouraged partnerships between tech firms and healthcare institutions to enhance remote patient monitoring through integrated biosensors.
A significant opportunity shaping the future of the North America pulse oximeter market is the growing demand for point-of-care and ambulatory monitoring solutions that enable real-time oxygen saturation tracking outside hospital settings. Emergency responders, ambulatory surgical centers, and rehabilitation clinics are increasingly adopting portable pulse oximeters to ensure patient safety during transport and outpatient procedures.
According to the American College of Emergency Physicians, over 70% of ambulance units in the U.S. now include pulse oximeters as standard equipment, facilitating immediate assessment of respiratory function in trauma and cardiac cases. Similarly, the Joint Commission has reinforced the inclusion of pulse oximetry in preoperative and post-anesthesia care protocols across ambulatory surgery centers. As per the Ontario Ministry of Health, funding programs supporting rural and remote healthcare have included provisions for expanding access to handheld oximeters in community clinics.
A major challenge facing the North America pulse oximeter market is the presence of technological limitations in low-cost portable models, particularly in terms of accuracy, reliability, and performance variability. While affordability has driven mass adoption of fingertip pulse oximeters among consumers, concerns about inconsistent readings especially under low-perfusion conditions have raised questions about their clinical utility. These inconsistencies were more pronounced in individuals with darker skin tones, raising ethical and safety concerns. In response, healthcare professionals have urged caution in relying solely on consumer-grade oximeters for medical decision-making. As per the American Association for Respiratory Care, clinicians recommend that patients with chronic respiratory conditions use clinically validated models rather than generic alternatives.
Another challenge confronting the North America pulse oximeter market is the limited reimbursement and insurance coverage for personal-use pulse oximeters, which restricts access for lower-income individuals despite rising demand for home-based health monitoring. Medicare Part B generally does not cover standalone pulse oximeters unless part of durable medical equipment prescriptions for home oxygen therapy. In Canada, provincial health plans provide limited coverage for pulse oximeters, primarily restricted to specialized home care programs and high-risk patient groups. As per the Canadian Medical Association Journal, out-of-pocket expenses remain a barrier for many patients seeking personal monitoring tools outside government-funded initiatives. This lack of consistent financial support hinders broader adoption, particularly among socioeconomically disadvantaged populations who could benefit most from continuous oxygen level tracking.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | % |
| Segments Covered | By Type, End-Use and Region. |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | U.S., Canada, Rest of North America |
| Market Leaders Profiled | Stryker, Medtronic, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc., Smiths Group plc, Honeywell International, Promed Technology Co., Ltd., Contec Medical Systems Co., Ltd., CONMED Corporation, Curbell Medical Products, Inc., Ecomed, Masimo, TytoCare Ltd., and BioIntelliSense, Inc |
Fingertip oximeters represented the biggest segment in the North America pulse oximeter market by capturing an estimated 48% of the total market share in 2024. This influence is primarily attributed to their compact size, ease of use, and affordability, making them ideal for both homecare settings and ambulatory monitoring. According to the American Association for Respiratory Care (AARC), over 60% of individuals managing chronic respiratory conditions at home prefer fingertip oximeters due to their portability and user-friendly design. These devices are widely used by patients with COPD, asthma, and sleep apnea for routine oxygen saturation checks without requiring professional assistance. In Canada, the Canadian Lung Association reported that general practitioners increasingly recommend fingertip oximeters as part of self-monitoring protocols for high-risk patients, particularly the elderly population suffering from declining lung function. As per Health Canada, these devices have become a standard component of personal health kits distributed under community health initiatives aimed at reducing hospitalizations. Also, the surge in telemedicine consultations has further fueled demand for fingertip oximeters, as healthcare providers encourage remote monitoring of vital signs.
The handheld oximeter segment is projected to grow at the quickest rate within the North America pulse oximeter market, registering a CAGR of 7.3%. This rapid expansion is driven by increasing adoption in emergency medical services, ambulance care, and rural healthcare delivery programs where durability and real-time readings are critical. According to the study, a high percentage of U.S. ambulance units now include handheld pulse oximeters as standard equipment, reflecting their importance in pre-hospital patient assessment. The American College of Emergency Physicians also highlighted that these devices are preferred for use in dynamic environments due to their larger displays and enhanced battery life.
Hospitals and other healthcare facilities accounted for the largest end-use segment in the North America pulse oximeter market, holding 62% of total market share in 2024. This is primarily driven by the widespread integration of pulse oximetry into clinical workflows for anesthesia, intensive care, and emergency medicine. According to the American Society of Anesthesiologists, pulse oximeters are considered essential monitoring tools during surgical procedures, with a large share of operating rooms using continuous oxygen saturation monitoring as part of standard practice. The Joint Commission has reinforced this requirement, mandating preoperative and postoperative oxygen level assessments. Additionally, the Public Health Agency of Canada noted that pulse oximeters were among the most frequently used diagnostic tools in emergency departments, especially during flu season and respiratory disease outbreaks.
The homecare segment is developing as the quickest advancing application area for pulse oximeters in North America, expanding at a CAGR of 8.1%. This growth is fueled by the increasing prevalence of chronic respiratory diseases, coupled with a shift toward decentralized healthcare delivery models that emphasize patient autonomy and remote monitoring. Telehealth platforms have encouraged physicians to prescribe personal pulse oximeters to facilitate virtual consultations with better data inputs. In Canada, Health Canada’s digital health strategy includes promoting the use of wearable and portable diagnostic tools, including pulse oximeters, to support aging-in-place initiatives.
The United States had the dominant position in the North America pulse oximeter market by capturing an estimated 67% of total regional consumption in 2024. This is underpinned by a large patient base suffering from chronic respiratory diseases, a robust healthcare infrastructure, and high adoption rates of advanced diagnostic technologies. The American Thoracic Society also notes that pulse oximetry has become a standard tool in both acute and long-term care settings. Moreover, the U.S. Food and Drug Administration (FDA) has played a pivotal role in regulating and certifying pulse oximeters, ensuring reliability and accuracy for both clinical and consumer use. With major manufacturers like Masimo, Nonin, and Apple developing innovative models tailored to different user groups, the U.S. remains at the forefront of technological advancement and market penetration.
Canada positioning reflects a strong healthcare system, rising incidence of respiratory illnesses, and increasing government support for home-based and remote patient monitoring solutions. The Canadian Lung Association emphasizes that early detection and consistent monitoring can significantly reduce hospitalization rates, reinforcing the need for accessible oximeter availability. In response, provincial health ministries have expanded reimbursement policies for pulse oximeters under chronic disease management programs. The Ontario Ministry of Health reported in 2024 that pulse oximeters were being integrated into community health packages for elderly and homebound patients.
The remaining North American countries are smaller but emerging markets. Many authorities and organizations have initiated pilot programs distributing low-cost oximeters in high-altitude regions where hypoxia is a common concern. While still a minor contributor to the overall market, this segment presents long-term potential for established players seeking geographic diversification and new consumer bases beyond traditional North American markets.
The competitive landscape of the North America pulse oximeter market is shaped by the presence of established medical device giants, emerging tech-driven startups, and regional manufacturers vying for market share in a rapidly evolving healthcare environment. Leading companies such as Masimo, Philips, and Medtronic dominate due to their strong brand recognition, deep-rooted relationships with healthcare providers, and continuous innovation in sensor technology and device integration.
At the same time, smaller firms and consumer electronics companies are entering the space with cost-effective, portable oximeters designed for home use, leveraging growing consumer interest in personal health monitoring. This dual-layered competition fosters innovation but also intensifies pressure on pricing and differentiation strategies.
Regulatory scrutiny remains a defining factor in market positioning, as accuracy concerns particularly among diverse skin tones have prompted stricter evaluation protocols from the FDA and Health Canada. Manufacturers must balance affordability with precision to meet both consumer expectations and clinical standards.
Moreover, the integration of pulse oximeters into wearable health devices has opened new battlegrounds between medical device firms and tech companies, further diversifying competition. As demand expands beyond traditional healthcare settings, the market continues to evolve, driven by technological advancements, regulatory developments, and shifting patient care paradigms.
Some of the companies that are playing a dominating role in the North America Pulse Oximeter Market include
Koninklijke Philips N.V.
Philips plays a pivotal role in the North America pulse oximeter market through its comprehensive portfolio of patient monitoring solutions integrated into hospital systems and homecare devices. The company offers advanced oximetry modules that are embedded in multi-parameter monitors used in intensive care, operating rooms, and emergency departments. In recent years, Philips has expanded its presence in the home health segment by introducing user-friendly oximeters compatible with connected health platforms. As a global leader in medical technology, Philips leverages its North American success to drive international product development and digital health integration strategies, reinforcing its leadership in both institutional and personal-use pulse oximeter categories.
Masimo Corporation
Masimo is a leading innovator in non-invasive patient monitoring technologies and holds a dominant position in the North America pulse oximeter market. Known for its proprietary Signal Extraction Technology, Masimo has redefined accuracy and reliability in oxygen saturation measurement, particularly under challenging conditions such as motion and low perfusion. The company's products are widely used in hospitals, emergency care units, and ambulatory settings across the U.S. and Canada. Globally, Masimo sets industry benchmarks through continuous R&D investment and strategic partnerships with healthcare providers, making it a key influencer in shaping global standards for pulse oximetry.
Medtronic plc
Medtronic is a major participant in the North America pulse oximeter market, offering a broad range of clinical-grade oximetry solutions tailored for acute care, anesthesia, and critical care applications. Its integration into existing patient monitoring systems enhances workflow efficiency in hospitals and surgical centers. Medtronic’s commitment to innovation is evident in its collaborations with research institutions and regulatory bodies to improve device performance across diverse patient populations. While primarily focused on professional healthcare settings, Medtronic also supports broader telehealth initiatives by enabling remote oxygen saturation tracking through compatible monitoring ecosystems. Its strong distribution network and reputation for quality make it a trusted name in the sector, contributing significantly to global advancements in patient safety and respiratory care management.
One major strategy employed by leading players in the North America pulse oximeter market is continuous technological innovation aimed at improving accuracy, usability, and integration with digital health platforms. Companies are investing heavily in sensor development, signal processing algorithms, and connectivity features to ensure seamless data transmission to electronic health records and mobile health apps.
Another key approach is expanding product accessibility through diversified distribution channels, including partnerships with retail pharmacies, e-commerce platforms, and telehealth service providers. By ensuring availability in both clinical and consumer markets, manufacturers are reaching a wider audience and adapting to evolving healthcare delivery models.
Lastly, strengthening clinical validation and regulatory compliance frameworks has become a priority for major players. With increasing scrutiny over device performance, especially in diverse patient populations, companies are conducting extensive clinical trials and collaborating with regulatory agencies to maintain credibility and ensure widespread adoption of their pulse oximeter technologies technology.
This research report on the North American pulse oximeter market has been segmented and sub-segmented into the following categories.
By Type
By End-use
By Country
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region